Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, September 2001, p. 1015-1017, Vol. 8, No. 5
The Göteborg Pertussis Vaccine Study,
The Göteborg Primary Health Care System,1
and the Department of Medical Microbiology and Immunology,
Göteborg University,2 Göteborg,
Sweden, and the National Institute of Child Health and
Human Development, National Institutes of Health, Bethesda, Maryland
208923
Received 2 February 2001/Returned for modification 27 March
2001/Accepted 21 May 2001
Serum immunoglobulin G (IgG) antibodies against the
lipooligosaccharide (LOS) of Bordetella pertussis and
the lipopolysaccharide (LPS) of Bordetella parapertussis
were measured by enzyme-linked immunosorbent assay in paired sera from
40 children with pertussis and 14 with parapertussis. Wide differences
in the individual responses were noted. Both anti-LOS and -LPS IgG
levels increased significantly in the children with pertussis, as did
anti-LPS but not anti-LOS in those with parapertussis.
1071-412X/01/$04.00+0 DOI: 10.1128/CDLI.8.5.1015-1017.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Serum Immunoglobulin G Antibody Responses to Bordetella
pertussis Lipooligosaccharide and B.
parapertussis Lipopolysaccharide in Children with
Pertussis and Parapertussis
*
Corresponding author: Birger Trollfors, Department of
Pediatrics, Sahlgrenska University Hospital-East, S-416 85 Göteborg, Sweden. Phone: 46 31 3434000. Fax: 46 31 84 30 10. E-mail: birger.trollfors{at}vgregion.se.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»